Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms

Table 3 Raw fluorescence data outputs across three flow analyzers (median fluorescence intensity, arbitrary units)

Sample ID	Instrument	A1AT	ANG	ApoE	CA9	IL-8	MMP-9	MMP-10	PAI-1	SDC1	VEGF-A
#0003	MagPix	3324	4901	1927	17	5712	1555	240	3062	2202	4163
Tumor	200	3407	4837	2085	20	5646	1694	273	3446	2439	4225
	FlexMap 3D	26,883	38,409	16,223	140	43,608	12,595	2253	26,844	19,223	32,058
#0146	MagPix	2889	1612	514	2	2876	150	3	1412	1663	962
Tumor	200	2991	1604	556	2	3090	185	4	1522	1782	1062
	FlexMap 3D	236,110	13,055	4246	17	23,851	1265	25	11,801	14,059	8080
#0147	MagPix	3825	325	22	0	406	32	0	72	579	20
Tumor	200	3774	342	27	0	467	45	1	81	664	27
	FlexMap 3D	28,626	2564	183	0	3352	262	0	618	4793	181
#0010	MagPix	105	5	6	0	1	1	1	0	131	9
Control	200	125	6	7	2	1	0	1	0	157	14
	FlexMap 3D	868	45	52	0	8	2	6	7	1083	96
#0145	MagPix	1226	22	251	0	6	1	0	2	2007	76
Control	200	1349	27	292	0	7	1	1	1	2257	95
	FlexMap 3D	10,045	176	2138	0	50	2	1	26	16,745	635
#0150	MagPix	128	1	1	0	1	1	1	1	443	0
Control	200	148	2	3	1	1	0	2	0	501	1
	FlexMap 3D	1039	18	5	1	6	0	5	4	3696	5

Shown are raw data outputs from six representative urine samples, from three confirmed BC subjects (“Tumor”) and three Control subjects. Values are averages of duplicate wells per analyte, per subject, rounded to the nearest whole number

ISSN: 1479-5876